Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 295-405-4 | CAS number: 92045-23-3 A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12°C to 5°C (10.4°F to 41°F).
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- one-generation reproductive toxicity
- Remarks:
- based on generations indicated in Effect levels (migrated information)
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- 2003 - 2008 (date final report signed by Study Director)
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant (except for test substance identity, stability and lot number), guideline study , available as unpublished report, no restrictions, fully adequate for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: EPA OPPTS 870.3650 (Combined repeated exposure toxicity study with the Reproduction/Developmental toxicity screening test)
- GLP compliance:
- yes
- Remarks:
- The identity and stability was not in compliance with GLP regulations. The lot number was not available.
- Limit test:
- no
Test material
- Reference substance name:
- Butane
- EC Number:
- 203-448-7
- EC Name:
- Butane
- Cas Number:
- 106-97-8
- Molecular formula:
- C4H10
- IUPAC Name:
- butane
- Details on test material:
- - Name of test material (as cited in study report): butane
- Physical state: colourless gas
- Analytical purity: 99.5% per supplier
- Analytical purity: 99.23% before study, 99.98% after study
- Lot/batch No.: not available
- Expiration date of the lot/batch: not available
- Stability under test conditions: confirmed
- Storage condition of test material: Ambient
- Other: An archival sample was stored.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Sprague-Dawley CD
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Raleigh, North Carolina 27610
- Age at study initiation: Approximately 8 weeks
- Weight at study initiation: males: 241-280 g (mean: 261 g); females 174-229 g (mean 200 g)
- Fasting period before study: none
- Housing: Individually in stainless steel suspended cages with wire mesh floors and fronts except during the mating period. From day 18 of gestation and during lactation, the each female was housed with her litter in plastic cages with bedding
- Diet: Certified Rodent Diet # 5002 (PMI Nutrition Int., St. Louis, Missouri) ad libitum
- Water: ad libitum
- Acclimation period: Approximately 2 weeks
ENVIRONMENTAL CONDITIONS
- Temperature 20.7-22.4°C
- Humidity: 24.28-77.36%
- Air changes (per hr): no data
- Photoperiod: 12 hrs dark / 12 hrs light
IN-LIFE DATES: From: 29 September 2003 To: 26 April 2006
Administration / exposure
- Route of administration:
- inhalation
- Type of inhalation exposure (if applicable):
- whole body
- Vehicle:
- other: air
- Details on exposure:
- Not detailed in main report, require access to Appendix II, Volume 3
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Whole-body inhalation chamber
- Method of holding animals in test chamber: Individually in stainless steel suspended cages with wire mesh floors and fronts
- Source and rate of air:
- Method of conditioning air:
- System of generating particulates/aerosols:
- Temperature, humidity, pressure in air chamber:
- Air flow rate:
- Air change rate:
- Method of particle size determination: yes
- Treatment of exhaust air:
TEST ATMOSPHERE
- Brief description of analytical method used: Infrared spectrophotometer (IR) 4 times per chamber per day
- Samples taken from breathing zone: yes - Details on mating procedure:
- - M/F ratio per cage: 1:1
- Length of cohabitation: until evidence of mating was seen, or for two consecutive weeks
- Proof of pregnancy: vaginal plug / sperm in vaginal smear referred to as day 0 of pregnancy
- After successful mating each pregnant female was caged (how): individually in plastic "shoebox" cages with bedding
- After the mating period was over, females without evidence of copulation were removed from the mating cages, housed individually and monitored for visible signs of pregnancy with corresponding bodyweight gain.
- Any other deviations from standard protocol: no - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Exposure levels were determined using an infrared spectrophotometer 4 times/chamber/day. The test substance was evenly distributed within each chamber. The mean (± SD) analytical concentrations were 0 ± 0, 930.6 ± 28.1, 3022 ± 58 and 9157 ± 269 ppm.
- Duration of treatment / exposure:
- Males for 2 weeks prior to mating and for an additional 28 days (minimum) after mating.
Females for 2 weeks prior to mating and gestation days 0-19. - Frequency of treatment:
- 6 hours/day, 7 days/week
- Details on study schedule:
- Females without evidence of mating that appeared to be pregnant were killed on an estimated gestation day 19.
Females that littered and their offspring were killed on post partum day 4.
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
0, 900, 3000 and 9000 ppm
Basis:
other: target concentration
- Remarks:
- Doses / Concentrations:
0.0 ± 0.0, 930.6 ± 28.1, 3022 ± 58, 9157 ± 269 ppm
Basis:
analytical conc.
- No. of animals per sex per dose:
- 12/sex/group
- Control animals:
- yes, sham-exposed
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: twice daily (mortality and clinical condition)
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: Male rats were examined prior to randomisation and once weekly throughout the study. Female rats were examined prior to randomisation and once weekly throughout the premating period and on gestation days 0, 7, 14, 20 and lactation days 0 (except if parturition was not completed on the same day), 1 and 4.
BODY WEIGHT: Yes
- Time schedule for examinations: Male rats were weighed at randomisation and then weekly throughout the study. Females were weighed at randomisation, on the first day of exposure and twice weekly until evidence of copulation was observed, on gestation days 0, 7, 14 and 20, and on lactation days 1 and 4. Females were not fasted prior to recording terminal bodyweights.
FOOD CONSUMPTION: Yes
- Time schedule for examinations: Once weekly throughout the premating period. For pregnant or confirmed mated females, food consumption was recorded on gestation days 0-7, 7-14, 14-20 and on lactation days 1-4.
WATER CONSUMPTION: No - Oestrous cyclicity (parental animals):
- No
- Sperm parameters (parental animals):
- During the microscopic examination of the testes, special emphasis was placed on the stages of spermatogenesis and the histopathology of interstitial testicular cell structure.
- Litter observations:
- STANDARDISATION OF LITTERS
- Performed on day 4 postpartum: no
PARAMETERS EXAMINED
The following parameters were examined in F1 offspring: Number of live and dead pups, pup abnormalities and sex of pups. Pups were observed twice daily (morning and afternoon).
Each pup was examined on lactation day 0 and 4.
Individual pup weights and sex were recorded on lactation days 1 and 4
GROSS EXAMINATION OF DEAD PUPS:
yes, for external and internal abnormalities; possible cause of death was not determined for pups born or found dead. - Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All surviving animals (after a minimum of 28 days post-mating).
- Maternal animals: All surviving animals (28 days post-mating).
GROSS EXAMINATION: Yes. Tissues examined: adrenal glands, bone (sternum/femur), bone marrow, brain (medulla/pons, cerebrum and cerebellum), epididymides, heart, kidneys, caecum, colon, rectum, larynx, liver, lungs (with mainstem bronchi), lymph nodes (mesenteric and mediastinal), mammary glands (with adjacent skin), nasopharynx, ovaries (with oviducts), prostate, seminal vesicles, duodenum, ileum, jejunum, spinal cord (cervical, thoracic and lumbar), spleen, stomach, testes, thymus, thyroid with parathyroids, tibial nerve, trachea, urinary bladder, uterus with vagina and all macroscopic lesions and tissue masses.
ORGAN WEIGHTS: Yes. Adrenal glands, brain, epididymides, heart, kidneys, liver, lungs, ovaries, spleen, testes, thymus and uterus with vagina.
HISTOPATHOLOGY: Yes. ORGAN WEIGHTS: Yes. Adrenal glands, brain, epididymides, heart, kidneys, liver, lungs, ovaries, spleen, testes, thymus and uterus with vagina.
HISTOPATHOLOGY: Yes (male and female main study only).
- tissues examined: adrenal glands, bone (sternum/femur), brain (cerebellum, cerebrum and cerebellum), epididymes, heart, kidneys, large intestine (caecum, colon and rectum), liver, lungs (with mainstream bronchi), lymph node (mesenteric), lymph node (mediastinal), mammary glands (with adjacent skin), ovaries (with oviducts), protate, seminal vesicles, smnall intestine (duodenum, ileum and jejunum), spinal cord (cervical, thoracic and lumbar), spleen, stomach, testes, thymus, thyroids with parathyroids, tibial nerve, trachea, urinary bladder, uterus with vagina, all macroscopic lesions and tissue masses. - Postmortem examinations (offspring):
- Macroscopic postmortem examinations (external only) were performed on all surviving F1 pups on lactation day 4.
- Statistics:
- Group mean values of parameters for all the exposure groups were compared to the control group mean values at each time interval, using appropriate statistical methods.
- Reproductive indices:
- Male and female mating indices, pregnancy rates, male and female fertility indices, gestation indices and the incidence of dams with no viable pups, were analysed statistically.
- Offspring viability indices:
- Live birth index, litter survival and mean pup survival indices (days 0 and 4) were analysed statistically.
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
Reproductive function / performance (P0)
- Reproductive performance:
- no effects observed
Details on results (P0)
Effect levels (P0)
open allclose all
- Dose descriptor:
- NOAEC
- Remarks:
- Reproductive effects
- Effect level:
- 9 000 ppm
- Sex:
- male/female
- Basis for effect level:
- other: No effects observed at the highest concentration tested.
- Dose descriptor:
- NOAEC
- Remarks:
- Reproductive effects
- Effect level:
- 21 394 mg/m³ air
- Sex:
- male/female
- Basis for effect level:
- other: No effects observed at the highest concentration tested.
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Gross pathological findings:
- no effects observed
Details on results (F1)
Effect levels (F1)
open allclose all
- Dose descriptor:
- NOAEC
- Remarks:
- Reproductive effects
- Generation:
- F1
- Effect level:
- 9 000 ppm
- Sex:
- male/female
- Basis for effect level:
- other: No effects observed at the highest concentration tested.
- Dose descriptor:
- NOAEC
- Remarks:
- Reproductive effects
- Generation:
- F1
- Effect level:
- 21 394 mg/m³ air
- Sex:
- male/female
- Basis for effect level:
- other: No effects observed at the highest concentration tested.
Overall reproductive toxicity
- Reproductive effects observed:
- no
Applicant's summary and conclusion
- Conclusions:
- There were no effects on gestation duration, number of live and dead pups, pup abnormalities or pup sex and weights. The NOAEC for butane for reproductive toxicity was 9000 ppm. Equivalent to 21394 mg/m3
- Executive summary:
The study assessed the potential toxicity, including neurotoxicity and reproductive performance in male and female rats following butane exposure at 900, 3000 and 9000 ppm. It also was designed to investigate effects inboth sexes on mating behavior and on gonadal function, as well as effects on conception, development, parturition and pup survival to lactation day 4.
Male and female rats were exposed for 6 hours/day, 7 days/week for 2 weeks prior to mating initiation. Main study females were evaluated for subchronic effects and were exposed once daily (6 hours/day), seven days/week for 4 weeks (28 days). A satellite group of females was evaluated for reproductive effects only - exposed once daily (6 hours/day), seven days/week for at least two weeks prior to mating initiation, then once daily during mating and gestation (days 0-19). For satellite female rats without evidence of mating that appeared to be pregnant, exposure was terminated on the estimated gestation day 19.Main study male rats were exposed during the mating and post-mating periods until euthanized for a minimum exposure of 28 days.
There was no effect on survival. There were no exposure-related clinical effects or effects on body weight, food consumption, FOB or motor activity parameters for either sex. Furthermore there were no exposure-related differences in haematology, clinical chemistry and no macroscopic or microscopic changes at post-mortem.
All mated female animals were found pregnant and delivered live pups. Mating indices for the butane male rats treated were comparable to control. Mating, fertility and gestation indices for the female rats were comparable to control. Most of the females in each group mated at the
first opportunity. There were also no treatment-related differences in the other reproductive parameters up to the time of parturition including the percent of females completing delivery and the duration of gestation. There were no treatment-related differences in all parturition parameters including the total number of pups delivered, the number of pups dying, the viability (4 day survival) index, the number of implantation sites and corpora lutea per dam, the pup sex ratio and the number of live pups/litter. The pups were unremarkable during the lactation period. There were no exposure-related differences in body weights or weight gains in the pups feeding from test substance exposed animals compared to the pups feeding from air control animals. Furthermore there were no macroscopic changes at post-mortem.Exposure of male and female rats to target concentrations of 900, 3000 and 9000 ppm of butane resulted in no general systemic effects, no effects on fertility and reproductive performance and no effects on pup survival and development to postnatal Day4.
A no observed adverse effect concentration (NOAEC) of 9000 ppm was determined for this study's systemic, reproductive, and neonatal endpoints. Equivalent to 21394 mg/m3 (MW 58.12g/mol).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.